CASI Pharmaceuticals Appoints Daniel Lang, MD as Chief Financial Officer
Monday, 8 July 2024, 12:10
CASI Pharmaceuticals Appoints Daniel Lang, MD as CFO
CASI Pharmaceuticals announces the appointment of Daniel Lang, MD as the new Chief Financial Officer and Senior Vice President, effective July 8, 2024. Lang, who previously served as the President of Athenex cell therapy, brings valuable expertise to his new role at CASI Pharmaceuticals.
Key Points:
- Appointment: Daniel Lang, MD named CFO
- Experience: Former President of Athenex cell therapy
- Effectiveness: Effective July 8, 2024
The appointment of Daniel Lang, MD as CFO signifies CASI Pharmaceuticals' commitment to enhancing its financial management capabilities and driving strategic growth.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.